Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig M Horbinski

Showing results (21-30 of 83) with videos related to

Pageof 9
Sort By:
Cancer Immunology, Immunotherapy : CII|April 29, 2019
Systemic and local immunosuppression in patients with high-grade meningiomasYuping D Li, Dorina Veliceasa, Jason B Lamano, et al.
Acta Neuropathologica Communications|April 19, 2017
Detection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline gliomaTina Y Huang, Andrea Piunti, Rishi R Lulla, et al.
Macromolecular Bioscience|January 15, 2026
High-Throughput 3D Glioblastoma Model in Glycosaminoglycan Hydrogels for Personalized Therapeutic ScreeningRajvinder Kaur Trautmann, Nicholas Dennison, Kathleen McCortney, et al.
Journal of Neuro-Oncology|February 2, 2019
Race influences survival in glioblastoma patients with KPS ≥ 80 and associates with genetic markers of retinoic acid metabolismMeijing Wu, Jason Miska, Ting Xiao, et al.
Neuro-Oncology|December 18, 2019
Toward a standard pathological and molecular characterization of recurrent glioma in adults: a Response Assessment in Neuro-Oncology effortAli S Haider, Martin van den Bent, Patrick Y Wen, et al.
Neuro-Oncology Practice|February 7, 2025
Clinical outcomes for pleomorphic xanthoastrocytoma patientsJared J Sullivan, James P Chandler, Maciej S Lesniak, et al.
Oral Oncology|August 18, 2020
Evaluation of antioxidant network proteins as novel prognostic biomarkers for head and neck cancer patientsChristina A Wicker, Vinita Takiar, Rangaswamy Suganya, et al.
Neuro-Oncology|February 15, 2020
LY6K promotes glioblastoma tumorigenicity via CAV-1-mediated ERK1/2 signaling enhancementNamratha G Sastry, Xuechao Wan, Tianzhi Huang, et al.
International Journal of Molecular Sciences|December 11, 2025
Targeting Survivin: Now I Become Death, the Destroyer of CellsMia Fanuzzi, Shuhua Zheng, Craig M Horbinski, et al.
Journal of Neuro-Oncology|September 10, 2024
Clinical and methylomic features of spinal meningiomasKhizar R Nandoliya, Harrshavasan Congivaram, Mark W Youngblood, et al.
Pageof 9

Showing results (21-30 of 83) with videos related to

Sort By:
Pageof 9
Cancer Immunology, Immunotherapy : CII|April 29, 2019
Systemic and local immunosuppression in patients with high-grade meningiomasYuping D Li, Dorina Veliceasa, Jason B Lamano, et al.
Acta Neuropathologica Communications|April 19, 2017
Detection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline gliomaTina Y Huang, Andrea Piunti, Rishi R Lulla, et al.
Macromolecular Bioscience|January 15, 2026
High-Throughput 3D Glioblastoma Model in Glycosaminoglycan Hydrogels for Personalized Therapeutic ScreeningRajvinder Kaur Trautmann, Nicholas Dennison, Kathleen McCortney, et al.
Journal of Neuro-Oncology|February 2, 2019
Race influences survival in glioblastoma patients with KPS ≥ 80 and associates with genetic markers of retinoic acid metabolismMeijing Wu, Jason Miska, Ting Xiao, et al.
Neuro-Oncology|December 18, 2019
Toward a standard pathological and molecular characterization of recurrent glioma in adults: a Response Assessment in Neuro-Oncology effortAli S Haider, Martin van den Bent, Patrick Y Wen, et al.
Neuro-Oncology Practice|February 7, 2025
Clinical outcomes for pleomorphic xanthoastrocytoma patientsJared J Sullivan, James P Chandler, Maciej S Lesniak, et al.
Oral Oncology|August 18, 2020
Evaluation of antioxidant network proteins as novel prognostic biomarkers for head and neck cancer patientsChristina A Wicker, Vinita Takiar, Rangaswamy Suganya, et al.
Neuro-Oncology|February 15, 2020
LY6K promotes glioblastoma tumorigenicity via CAV-1-mediated ERK1/2 signaling enhancementNamratha G Sastry, Xuechao Wan, Tianzhi Huang, et al.
International Journal of Molecular Sciences|December 11, 2025
Targeting Survivin: Now I Become Death, the Destroyer of CellsMia Fanuzzi, Shuhua Zheng, Craig M Horbinski, et al.
Journal of Neuro-Oncology|September 10, 2024
Clinical and methylomic features of spinal meningiomasKhizar R Nandoliya, Harrshavasan Congivaram, Mark W Youngblood, et al.
Pageof 9